| Literature DB >> 22871020 |
Debbie Wierenga1, Luuk H Engbers, Pepijn van Empelen, Vincent H Hildebrandt, Willem van Mechelen.
Abstract
BACKGROUND: Worksite health promotion programs (WHPPs) offer an attractive opportunity to improve the lifestyle of employees. Nevertheless, broad scale and successful implementation of WHPPs in daily practice often fails. In the present study, called BRAVO@Work, a 7-step implementation strategy was used to develop, implement and embed a WHPP in two different worksites with a focus on multiple lifestyle interventions.This article describes the design and framework for the formative evaluation of this 7-step strategy under real-time conditions by an embedded scientist with the purpose to gain insight into whether this this 7-step strategy is a useful and effective implementation strategy. Furthermore, we aim to gain insight into factors that either facilitate or hamper the implementation process, the quality of the implemented lifestyle interventions and the degree of adoption, implementation and continuation of these interventions. METHODS ANDEntities:
Mesh:
Year: 2012 PMID: 22871020 PMCID: PMC3490970 DOI: 10.1186/1471-2458-12-619
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Framework presenting the innovation process and related innovation determinants (Fleuren et al., [25]).
Figure 2Outline of the 7-step strategy for implementation and continuation of a worksite health policy.
Definition of the formative evaluation components at three organizational levels, including methods for data collection
| Recruitment | Monitoring | ||
| | | Sources and procedures used to approach and attract worksites and management to become effective participants of the project | |
| | | Monitoring, questionnaire, interviews | |
| | | Sources and procedures used to approach and attract PG and WG members to become effective program members | |
| | | Monitoring, questionnaire, interviews | |
| | | Sources and procedures used to approach and attract employees for participation in BRAVO-interventions to become effective participants | |
| Reach | Monitoring, interviews | ||
| | | Proportion of employees who were approached as PG or WG member | |
| | | Monitoring | |
| | | Proportion of employees who were approached for participation in BRAVO-interventions | |
| | Dose delivered | Monitoring | |
| | | Providing the 7-step strategy to worksites and PG and WG members | |
| | | Monitoring, questionnaire, interviews | |
| | | Proportion of intended BRAVO-interventions delivered or provided to employees by PG and WG | |
| | Dose Received | Monitoring | |
| | | Proportion of companies and PG and WG members who received the 7-step implementation strategy | |
| | | Monitoring, questionnaire, interviews | |
| | | Proportion of employees who participated in each BRAVO-intervention | |
| | Fidelity | Monitoring, questionnaire, interviews | |
| | | - Compliance to the 7 steps of the implementation strategy by Steering committee and PG | |
| | Satisfaction | Interviews | |
| | | Opinion/satisfaction about the project | |
| | | Questionnaire, interviews | |
| | | Opinion/satisfaction about the 7-step strategy | |
| | | Questionnaire, interviews | |
| | | Opinion/satisfaction about BRAVO-interventions | |
| Maintenance | Monitoring, questionnaire, interviews | ||
| | | Extend to which the developed BRAVO-interventions and 7-step strategy become routine and part of everyday culture and norms of the organization including the degree to which BRAVO-interventions are continued. | |
| Context | Monitoring, | ||
| | Determinants of implementation which can either hinder or facilitate the implementation of the 7-step strategy and BRAVO-interventions. These determinants are subdivided within 4 main categories: | questionnaire, interviews | |
| | | 1. Characteristics of the socio-political context | |
| | | 2. Characteristics of the organization | |
| | | 3. Characteristics of the innovation | |
| 4. Characteristics of the adopting person/user |
*PG = project group.
*WG = working group.
Implementation determinants measured in this study, sub dived per main category
| 1. Willingness of participants to cooperate with the innovation | |
| 2. Degree to which the participant is aware of the health benefits of the innovation | |
| 3. The extent to which the innovation fits into existing rules, regulations and legislation | |
| 4. Decision making process and procedures in the organization: top-down or bottom-up | |
| | 5. Hierarchical structure: extent to which decision making process is formalized through hierarchical procedures |
| 6. Formal reinforcement by management to integrate the innovation into organizational policies | |
| 7. Organizational size (number of employees): large, medium, small | |
| 8. Functional structure (task oriented) versus product structure (output oriented) | |
| 9. Staff turnover: high, average, low | |
| 10. Degree of staff capacity in the organization or department that implements the innovation | |
| 11. Available expertise, in relation to the innovation in the organization or department | |
| 12. Number of potential users to be reached | |
| 13. Financial resources made available for implementing the innovation | |
| 14. Reimbursement for implementers/organizations to facilitate extra efforts in applying the innovation | |
| 15. Other resources made available for implementing the innovation (e.g. equipment, manuals) | |
| 16. Administrative support available to the implementers of the innovation | |
| 17. Time available to implement the innovation | |
| 18. Availability of staff responsible for coordinating implementation in the organization | |
| | 19. The implementers are involved in the development of the innovation |
| 20. Opinion leaders who influence opinions of others in the organization or department | |
| 21. Cooperation with external partners with respect to the implementation of the innovation | |
| 22. Support from colleagues in implementing the innovation | |
| 23. Support from other implementers within the project in implementing the innovation | |
| 24. Support from their supervisors in the department with respect to the implementation of the innovation | |
| 25. Support from higher management in the organization with respect to the implementation of the innovation | |
| | 26. Extent to which colleagues implement the innovation (modeling) |
| 27. Extent to which the implementer has the skills needed to implement the innovation | |
| 28. Extent to which the implementer has the knowledge needed to implement the innovation | |
| 29. Self-efficacy: confidence of the implementer to perform the behavior needed to implement the innovation | |
| 30. Extent to which ownership by the implementer is perceived | |
| 31. Extent to which the innovation first the perceived task orientation of the implementer | |
| 32. Extent to which the implementer expects that the participant will cooperate with the innovation | |
| 33. Extent to which the implementer expects that the participant will be satisfied with the innovation | |
| 34. Extent to which the goals of the different implementers with respect to the innovation are contradictory | |
| 35. Extent to which the implementer has ethical problems with the innovation | |
| 36. Attitude of the implementer with respect to the innovation | |
| 37. Outcome expectations of the implementer and participants with respect to the innovation | |
| 38. Perceived social norm with respect to the innovation by colleagues and supervisors | |
| 39. User directed performance feedback: formative or summative feedback | |
| 40. Personal benefits for the implementers | |
| 41. Extent to which the implementers work as a team | |
| 42. Extent to which the procedures/guidelines of the innovation are clear | |
| 43. Extent to which the procedures/guidelines are read by the implementers | |
| 44. Extent to which the innovation is complete | |
| 45. Extent to which the innovation is too complex to work with | |
| 46. Information provided: sufficient, insufficient. | |
| 47. Compatibility: degree to which the innovation is perceived as consistent with existing work procedures | |
| 48. Triability: extent to which the innovation can be subjected to trial | |
| 49. Relative advantage: extent to which the innovation is perceived as advantageous | |
| 50. Observability: degree to which the results of the innovations are observable to the implementer | |
| 51. Extent to which the innovation is appealing to use | |
| 52. Relevance of the innovation for the participant: extent to which the innovation has added value | |
| 53. Frequency of use of the innovation: high, low | |
| 54. Image of the innovation in the organization: positive, negative |